AVLSA
Atlas Venture Life Science Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.8M | Hold |
6,430,257
| – | – | 6.31% | 7 |
|
|
2025
Q1 | $51M | Hold |
6,430,257
| – | – | 9.77% | 4 |
|
|
2024
Q4 | $81.5M | Hold |
6,430,257
| – | – | 9.94% | 5 |
|
|
2024
Q3 | $89.6M | Hold |
6,430,257
| – | – | 8.3% | 6 |
|
|
2024
Q2 | $88.6M | Hold |
6,430,257
| – | – | 9.33% | 5 |
|
|
2024
Q1 | $106M | Sell |
6,430,257
-1,178,137
| -15% | -$19.5M | 9.8% | 4 |
|
|
2023
Q4 | $111M | Hold |
7,608,394
| – | – | 13.23% | 5 |
|
|
2023
Q3 | $93.4M | Hold |
7,608,394
| – | – | 14.46% | 2 |
|
|
2023
Q2 | $90.8M | Hold |
7,608,394
| – | – | 11.31% | 4 |
|
|
2023
Q1 | $102M | Buy |
7,608,394
+40,077
| +0.5% | +$536K | 13.77% | 3 |
|
|
2022
Q4 | $163M | Sell |
7,568,317
-600,854
| -7% | -$12.9M | 19.62% | 1 |
|
|
2022
Q3 | $164M | Sell |
8,169,171
-799,134
| -9% | -$16M | 18.06% | 2 |
|
|
2022
Q2 | $161M | Buy |
8,968,305
+766,667
| +9% | +$13.7M | 26.84% | 1 |
|
|
2022
Q1 | $81.4M | Hold |
8,201,638
| – | – | 10.29% | 3 |
|
|
2021
Q4 | $138M | Buy |
+8,201,638
| New | +$138M | 12.69% | 2 |
|